(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
(Address of principal executive offices) | (Zip Code) |
Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||
Emerging growth company | |||||||||||
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. | ☐ |
Exhibit No. | Description | ||||
104* | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
BRIGHTHOUSE FINANCIAL, INC. | |||||||||||
By: | /s/ Kristine H. Toscano | ||||||||||
Name: | Kristine H. Toscano | ||||||||||
Title: | Chief Accounting Officer |
Table of Contents | Financial Results | |||||||
Earnings and Select Metrics from Segments and Corporate & Other | ||||||||
Corporate & Other — Statements of Adjusted Earnings and Select Operating Metrics | ||||||||
Other Information | ||||||||
Appendix | ||||||||
A-2 | ||||||||
A-6 | ||||||||
A-7 | ||||||||
A-8 | ||||||||
A-9 | ||||||||
A-10 |
Financial Supplement | 1 |
As of or For the Three Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
Financial Results and Metrics (1) | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | |||||||||||||||||||||||||||||||||||||||
Net income (loss) available to shareholders | $150 | $9 | $(519) | $(942) | $453 | |||||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) (2) | $767 | $346 | $(98) | $177 | $326 | |||||||||||||||||||||||||||||||||||||||
Adjusted earnings, less notable items (2) | $243 | $346 | $268 | $189 | $275 | |||||||||||||||||||||||||||||||||||||||
Total corporate expenses (3) | $203 | $200 | $207 | $244 | $210 | |||||||||||||||||||||||||||||||||||||||
Combined total adjusted capital (4) | $5,700 | $5,397 | $6,030 | $6,283 | $7,251 | |||||||||||||||||||||||||||||||||||||||
Combined risk-based capital ratio (4), (5) | 400%-420% | 380%-400% | 415%-435% | 428% | 400%-420% | |||||||||||||||||||||||||||||||||||||||
Stockholders' Equity | ||||||||||||||||||||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s stockholders’ equity | $5,525 | $4,141 | $4,195 | $4,943 | $4,069 | |||||||||||||||||||||||||||||||||||||||
Less: Preferred stock, net | 1,699 | 1,699 | 1,699 | 1,699 | 1,699 | |||||||||||||||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s common stockholders’ equity, including AOCI | $3,826 | $2,442 | $2,496 | $3,244 | $2,370 | |||||||||||||||||||||||||||||||||||||||
Less: AOCI | (4,127) | (5,419) | (5,413) | (5,246) | (7,116) | |||||||||||||||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s common stockholders’ equity, excluding AOCI | $7,953 | $7,861 | $7,909 | $8,490 | $9,486 | |||||||||||||||||||||||||||||||||||||||
Return on Common Equity (1) | ||||||||||||||||||||||||||||||||||||||||||||
Return on common equity | (45.3)% | (36.3)% | (39.3)% | (36.3)% | (4.9)% | |||||||||||||||||||||||||||||||||||||||
Return on common equity, excluding AOCI | (15.6)% | (11.7)% | (13.6)% | (13.1)% | (1.7)% | |||||||||||||||||||||||||||||||||||||||
Adjusted return on common equity, excluding AOCI | 14.3% | 8.8% | 7.6% | 10.5% | 14.0% | |||||||||||||||||||||||||||||||||||||||
Earnings Per Common Share, Diluted (1), (6) | ||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) available to shareholders per common share | $2.47 | $0.12 | $(8.22) | $(14.70) | $6.89 | |||||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) per common share | $12.58 | $5.57 | $(1.56) | $2.73 | $4.97 | |||||||||||||||||||||||||||||||||||||||
Adjusted earnings, less notable items per common share | $3.99 | $5.57 | $4.25 | $2.92 | $4.18 | |||||||||||||||||||||||||||||||||||||||
Weighted average common shares outstanding | 60,949,819 | 62,255,330 | 63,036,773 | 64,820,914 | 65,744,351 | |||||||||||||||||||||||||||||||||||||||
Book Value Per Common Share | ||||||||||||||||||||||||||||||||||||||||||||
Book value per common share (1) | $63.94 | $39.87 | $39.88 | $51.08 | $36.63 | |||||||||||||||||||||||||||||||||||||||
Book value per common share, excluding AOCI (1) | $132.91 | $128.36 | $126.35 | $133.69 | $146.61 | |||||||||||||||||||||||||||||||||||||||
Ending common shares outstanding | 59,838,034 | 61,243,957 | 62,595,426 | 63,503,355 | 64,703,557 | |||||||||||||||||||||||||||||||||||||||
(1) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||||||||||||||
(2) See additional information regarding notable items on page 18. | ||||||||||||||||||||||||||||||||||||||||||||
(3) Includes functional department expenses, public company expenses, certain investment expenses, retirement funding and incentive compensation. | ||||||||||||||||||||||||||||||||||||||||||||
(4) Reflects preliminary statutory results as of or for the three months ended September 30, 2024. See additional information on page 22. | ||||||||||||||||||||||||||||||||||||||||||||
(5) The RBC ratio is reported as a preliminary range for all periods, except those ended December 31. | ||||||||||||||||||||||||||||||||||||||||||||
(6) For loss periods, dilutive shares were not included in the calculation of net income (loss) available to shareholders per common share or adjusted earnings (loss) per common share as inclusion of such shares would have an anti-dilutive effect. |
Financial Supplement | 2 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Revenues | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Premiums | $180 | $181 | $202 | $226 | $194 | $563 | $602 | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 560 | 580 | 436 | 546 | 542 | 1,576 | 1,749 | |||||||||||||||||||||||||||||||||||||
Net investment income | 1,288 | 1,307 | 1,254 | 1,207 | 1,202 | 3,849 | 3,457 | |||||||||||||||||||||||||||||||||||||
Other revenues | 143 | 141 | 145 | 135 | 125 | 429 | 348 | |||||||||||||||||||||||||||||||||||||
Revenues before NIGL and NDGL | 2,171 | 2,209 | 2,037 | 2,114 | 2,063 | 6,417 | 6,156 | |||||||||||||||||||||||||||||||||||||
Net investment gains (losses) | (60) | (120) | (42) | (33) | (53) | (222) | (213) | |||||||||||||||||||||||||||||||||||||
Net derivative gains (losses) | (93) | (662) | (1,921) | (681) | (840) | (2,676) | (3,226) | |||||||||||||||||||||||||||||||||||||
Total revenues | $2,018 | $1,427 | $74 | $1,400 | $1,170 | $3,519 | $2,717 | |||||||||||||||||||||||||||||||||||||
Expenses | ||||||||||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | $22 | $642 | $968 | $710 | $590 | $1,632 | $1,966 | |||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | 556 | 509 | 502 | 525 | 426 | 1,567 | 1,300 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | 150 | 150 | 151 | 152 | 155 | 451 | 468 | |||||||||||||||||||||||||||||||||||||
Change in market risk benefits | 610 | (356) | (1,440) | 663 | (1,064) | (1,186) | (2,170) | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | 38 | 38 | 38 | 39 | 38 | 114 | 114 | |||||||||||||||||||||||||||||||||||||
Other expenses | 454 | 430 | 469 | 485 | 435 | 1,353 | 1,339 | |||||||||||||||||||||||||||||||||||||
Total expenses | 1,830 | 1,413 | 688 | 2,574 | 580 | 3,931 | 3,017 | |||||||||||||||||||||||||||||||||||||
Income (loss) before provision for income tax | 188 | 14 | (614) | (1,174) | 590 | (412) | (300) | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 10 | (20) | (123) | (258) | 109 | (133) | (109) | |||||||||||||||||||||||||||||||||||||
Net income (loss) | 178 | 34 | (491) | (916) | 481 | (279) | (191) | |||||||||||||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 2 | — | 2 | 1 | 2 | 4 | 4 | |||||||||||||||||||||||||||||||||||||
Net income (loss) attributable to Brighthouse Financial, Inc. | 176 | 34 | (493) | (917) | 479 | (283) | (195) | |||||||||||||||||||||||||||||||||||||
Less: Preferred stock dividends | 26 | 25 | 26 | 25 | 26 | 77 | 77 | |||||||||||||||||||||||||||||||||||||
Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | $150 | $9 | $(519) | $(942) | $453 | $(360) | $(272) |
Financial Supplement | 3 |
As of | ||||||||||||||||||||||||||||||||
ASSETS | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | |||||||||||||||||||||||||||
Investments: | ||||||||||||||||||||||||||||||||
Fixed maturity securities available-for-sale | $83,298 | $80,581 | $80,474 | $80,991 | $75,433 | |||||||||||||||||||||||||||
Equity securities | 87 | 85 | 86 | 102 | 90 | |||||||||||||||||||||||||||
Mortgage loans | 22,938 | 22,641 | 22,670 | 22,508 | 22,682 | |||||||||||||||||||||||||||
Policy loans | 1,387 | 1,470 | 1,651 | 1,331 | 1,311 | |||||||||||||||||||||||||||
Limited partnerships and limited liability companies | 4,870 | 4,938 | 4,920 | 4,946 | 4,931 | |||||||||||||||||||||||||||
Short-term investments | 1,812 | 1,390 | 1,347 | 1,169 | 1,003 | |||||||||||||||||||||||||||
Other invested assets | 4,462 | 4,194 | 4,746 | 4,409 | 3,210 | |||||||||||||||||||||||||||
Total investments | 118,854 | 115,299 | 115,894 | 115,456 | 108,660 | |||||||||||||||||||||||||||
Cash and cash equivalents | 5,630 | 4,441 | 3,823 | 3,851 | 3,839 | |||||||||||||||||||||||||||
Accrued investment income | 2,083 | 1,169 | 1,297 | 1,183 | 1,143 | |||||||||||||||||||||||||||
Reinsurance recoverables | 20,085 | 19,369 | 19,570 | 19,213 | 18,597 | |||||||||||||||||||||||||||
Premiums and other receivables | 607 | 674 | 664 | 548 | 469 | |||||||||||||||||||||||||||
DAC and VOBA | 4,745 | 4,791 | 4,829 | 4,872 | 4,919 | |||||||||||||||||||||||||||
Current income tax recoverable | 28 | 28 | 28 | 27 | 31 | |||||||||||||||||||||||||||
Deferred income tax asset | 1,737 | 2,087 | 2,063 | 1,893 | 2,121 | |||||||||||||||||||||||||||
Market risk benefit assets | 750 | 916 | 839 | 656 | 694 | |||||||||||||||||||||||||||
Other assets | 324 | 404 | 349 | 370 | 368 | |||||||||||||||||||||||||||
Separate account assets | 90,313 | 88,260 | 90,332 | 88,271 | 82,675 | |||||||||||||||||||||||||||
Total assets | $245,156 | $237,438 | $239,688 | $236,340 | $223,516 | |||||||||||||||||||||||||||
LIABILITIES AND EQUITY | ||||||||||||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||||||||
Future policy benefits | $32,781 | $31,886 | $32,245 | $32,569 | $30,404 | |||||||||||||||||||||||||||
Policyholder account balances | 87,678 | 85,865 | 84,159 | 81,068 | 78,371 | |||||||||||||||||||||||||||
Market risk benefit liabilities | 9,580 | 8,708 | 8,964 | 10,323 | 8,830 | |||||||||||||||||||||||||||
Other policy-related balances | 3,853 | 3,796 | 3,798 | 3,836 | 3,806 | |||||||||||||||||||||||||||
Payables for collateral under securities loaned and other transactions | 3,764 | 3,906 | 3,653 | 3,670 | 3,941 | |||||||||||||||||||||||||||
Long-term debt | 3,155 | 3,155 | 3,155 | 3,156 | 3,157 | |||||||||||||||||||||||||||
Other liabilities | 8,442 | 7,656 | 9,122 | 8,439 | 8,198 | |||||||||||||||||||||||||||
Separate account liabilities | 90,313 | 88,260 | 90,332 | 88,271 | 82,675 | |||||||||||||||||||||||||||
Total liabilities | 239,566 | 233,232 | 235,428 | 231,332 | 219,382 | |||||||||||||||||||||||||||
Equity | ||||||||||||||||||||||||||||||||
Preferred stock, at par value | — | — | — | — | — | |||||||||||||||||||||||||||
Common stock, at par value | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||||||
Additional paid-in capital | 13,953 | 13,972 | 13,989 | 14,004 | 14,022 | |||||||||||||||||||||||||||
Retained earnings (deficit) | (1,790) | (1,966) | (2,000) | (1,507) | (590) | |||||||||||||||||||||||||||
Treasury stock | (2,512) | (2,447) | (2,382) | (2,309) | (2,248) | |||||||||||||||||||||||||||
Accumulated other comprehensive income (loss) | (4,127) | (5,419) | (5,413) | (5,246) | (7,116) | |||||||||||||||||||||||||||
Total Brighthouse Financial, Inc.’s stockholders’ equity | 5,525 | 4,141 | 4,195 | 4,943 | 4,069 | |||||||||||||||||||||||||||
Noncontrolling interests | 65 | 65 | 65 | 65 | 65 | |||||||||||||||||||||||||||
Total equity | 5,590 | 4,206 | 4,260 | 5,008 | 4,134 | |||||||||||||||||||||||||||
Total liabilities and equity | $245,156 | $237,438 | $239,688 | $236,340 | $223,516 |
Financial Supplement | 5 |
For the Three Months Ended September 30, 2024 | ||||||||||||||||||||||||||||||||
Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
Premiums | $62 | $117 | $1 | $— | $180 | |||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 396 | 70 | 94 | — | 560 | |||||||||||||||||||||||||||
Net investment income | 729 | 112 | 275 | 178 | 1,294 | |||||||||||||||||||||||||||
Other revenues | 127 | 4 | 7 | 5 | 143 | |||||||||||||||||||||||||||
Total adjusted revenues | $1,314 | $303 | $377 | $183 | $2,177 | |||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||
Policyholder benefits and claims | $88 | $247 | $(313) | $— | $22 | |||||||||||||||||||||||||||
Interest credited to policyholder account balances | 341 | 26 | 60 | 118 | 545 | |||||||||||||||||||||||||||
Amortization of DAC and VOBA | 127 | 23 | — | — | 150 | |||||||||||||||||||||||||||
Interest expense on debt | — | — | — | 38 | 38 | |||||||||||||||||||||||||||
Other operating costs | 355 | 39 | 46 | 14 | 454 | |||||||||||||||||||||||||||
Total adjusted expenses | 911 | 335 | (207) | 170 | 1,209 | |||||||||||||||||||||||||||
Adjusted earnings (loss) before provision for income tax | 403 | (32) | 584 | 13 | 968 | |||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 76 | (7) | 121 | (17) | 173 | |||||||||||||||||||||||||||
Adjusted earnings (loss) after provision for income tax | 327 | (25) | 463 | 30 | 795 | |||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | — | — | — | 2 | 2 | |||||||||||||||||||||||||||
Less: Preferred stock dividends | — | — | — | 26 | 26 | |||||||||||||||||||||||||||
Adjusted earnings (loss) | $327 | $(25) | $463 | $2 | $767 | |||||||||||||||||||||||||||
For the Three Months Ended September 30, 2023 | ||||||||||||||||||||||||||||||||
Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
Premiums | $68 | $124 | $2 | $— | $194 | |||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 380 | 57 | 105 | — | 542 | |||||||||||||||||||||||||||
Net investment income | 652 | 115 | 300 | 160 | 1,227 | |||||||||||||||||||||||||||
Other revenues | 114 | 3 | 6 | 2 | 125 | |||||||||||||||||||||||||||
Total adjusted revenues | $1,214 | $299 | $413 | $162 | $2,088 | |||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||
Policyholder benefits and claims | $105 | $302 | $183 | $— | $590 | |||||||||||||||||||||||||||
Interest credited to policyholder account balances | 246 | 25 | 67 | 103 | 441 | |||||||||||||||||||||||||||
Amortization of DAC and VOBA | 129 | 26 | — | — | 155 | |||||||||||||||||||||||||||
Interest expense on debt | — | — | — | 38 | 38 | |||||||||||||||||||||||||||
Other operating costs | 341 | 39 | 43 | 12 | 435 | |||||||||||||||||||||||||||
Total adjusted expenses | 821 | 392 | 293 | 153 | 1,659 | |||||||||||||||||||||||||||
Adjusted earnings (loss) before provision for income tax | 393 | (93) | 120 | 9 | 429 | |||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 74 | (20) | 25 | (4) | 75 | |||||||||||||||||||||||||||
Adjusted earnings (loss) after provision for income tax | 319 | (73) | 95 | 13 | 354 | |||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | — | — | — | 2 | 2 | |||||||||||||||||||||||||||
Less: Preferred stock dividends | — | — | — | 26 | 26 | |||||||||||||||||||||||||||
Adjusted earnings (loss) | $319 | $(73) | $95 | $(15) | $326 |
Financial Supplement | 6 |
For the Nine Months Ended September 30, 2024 | ||||||||||||||||||||||||||||||||
Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
Premiums | $208 | $354 | $1 | $— | $563 | |||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 1,231 | 112 | 233 | — | 1,576 | |||||||||||||||||||||||||||
Net investment income | 2,107 | 340 | 906 | 524 | 3,877 | |||||||||||||||||||||||||||
Other revenues | 386 | 11 | 22 | 10 | 429 | |||||||||||||||||||||||||||
Total adjusted revenues | $3,932 | $817 | $1,162 | $534 | $6,445 | |||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||
Policyholder benefits and claims | $342 | $552 | $738 | $— | $1,632 | |||||||||||||||||||||||||||
Interest credited to policyholder account balances | 972 | 76 | 182 | 336 | 1,566 | |||||||||||||||||||||||||||
Amortization of DAC and VOBA | 380 | 71 | — | — | 451 | |||||||||||||||||||||||||||
Interest expense on debt | — | — | — | 114 | 114 | |||||||||||||||||||||||||||
Other operating costs | 1,040 | 144 | 127 | 42 | 1,353 | |||||||||||||||||||||||||||
Total adjusted expenses | 2,734 | 843 | 1,047 | 492 | 5,116 | |||||||||||||||||||||||||||
Adjusted earnings (loss) before provision for income tax | 1,198 | (26) | 115 | 42 | 1,329 | |||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 226 | (7) | 23 | (9) | 233 | |||||||||||||||||||||||||||
Adjusted earnings (loss) after provision for income tax | 972 | (19) | 92 | 51 | 1,096 | |||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | — | — | — | 4 | 4 | |||||||||||||||||||||||||||
Less: Preferred stock dividends | — | — | — | 77 | 77 | |||||||||||||||||||||||||||
Adjusted earnings (loss) | $972 | $(19) | $92 | $(30) | $1,015 | |||||||||||||||||||||||||||
For the Nine Months Ended September 30, 2023 | ||||||||||||||||||||||||||||||||
Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
Premiums | $218 | $381 | $3 | $— | $602 | |||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 1,209 | 192 | 348 | — | 1,749 | |||||||||||||||||||||||||||
Net investment income | 1,879 | 334 | 870 | 460 | 3,543 | |||||||||||||||||||||||||||
Other revenues | 324 | 8 | 20 | (4) | 348 | |||||||||||||||||||||||||||
Total adjusted revenues | $3,630 | $915 | $1,241 | $456 | $6,242 | |||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||
Policyholder benefits and claims | $319 | $697 | $950 | $— | $1,966 | |||||||||||||||||||||||||||
Interest credited to policyholder account balances | 753 | 69 | 203 | 284 | 1,309 | |||||||||||||||||||||||||||
Amortization of DAC and VOBA | 388 | 80 | — | — | 468 | |||||||||||||||||||||||||||
Interest expense on debt | — | — | — | 114 | 114 | |||||||||||||||||||||||||||
Other operating costs | 1,033 | 144 | 123 | 39 | 1,339 | |||||||||||||||||||||||||||
Total adjusted expenses | 2,493 | 990 | 1,276 | 437 | 5,196 | |||||||||||||||||||||||||||
Adjusted earnings (loss) before provision for income tax | 1,137 | (75) | (35) | 19 | 1,046 | |||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 213 | (18) | (8) | (14) | 173 | |||||||||||||||||||||||||||
Adjusted earnings (loss) after provision for income tax | 924 | (57) | (27) | 33 | 873 | |||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | — | — | — | 4 | 4 | |||||||||||||||||||||||||||
Less: Preferred stock dividends | — | — | — | 77 | 77 | |||||||||||||||||||||||||||
Adjusted earnings (loss) | $924 | $(57) | $(27) | $(48) | $792 |
Financial Supplement | 7 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Adjusted revenues | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Premiums | $62 | $63 | $83 | $93 | $68 | $208 | $218 | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 396 | 419 | 416 | 355 | 380 | 1,231 | 1,209 | |||||||||||||||||||||||||||||||||||||
Net investment income | 729 | 702 | 676 | 689 | 652 | 2,107 | 1,879 | |||||||||||||||||||||||||||||||||||||
Other revenues | 127 | 130 | 129 | 111 | 114 | 386 | 324 | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $1,314 | $1,314 | $1,304 | $1,248 | $1,214 | $3,932 | $3,630 | |||||||||||||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | $88 | $109 | $145 | $161 | $105 | $342 | $319 | |||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | 341 | 328 | 303 | 301 | 246 | 972 | 753 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | 127 | 126 | 127 | 128 | 129 | 380 | 388 | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Other operating costs | 355 | 341 | 344 | 358 | 341 | 1,040 | 1,033 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | 911 | 904 | 919 | 948 | 821 | 2,734 | 2,493 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | 403 | 410 | 385 | 300 | 393 | 1,198 | 1,137 | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 76 | 78 | 72 | 55 | 74 | 226 | 213 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings | $327 | $332 | $313 | $245 | $319 | $972 | $924 |
Financial Supplement | 8 |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
VARIABLE AND SHIELD LEVEL ANNUITIES ACCOUNT VALUE (1) | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | |||||||||||||||||||||||||||
Account value, beginning of period | $124,488 | $125,072 | $120,720 | $112,761 | $117,975 | |||||||||||||||||||||||||||
Premiums and deposits (2) | 2,098 | 2,254 | 2,084 | 2,003 | 2,077 | |||||||||||||||||||||||||||
Withdrawals, surrenders and contract benefits | (4,078) | (3,870) | (3,839) | (3,456) | (3,129) | |||||||||||||||||||||||||||
Net flows (3) | (1,980) | (1,616) | (1,755) | (1,453) | (1,052) | |||||||||||||||||||||||||||
Investment performance (4) | 6,318 | 1,598 | 6,624 | 9,945 | (3,604) | |||||||||||||||||||||||||||
Policy charges and other | (592) | (566) | (517) | (533) | (558) | |||||||||||||||||||||||||||
Account value, end of period | $128,234 | $124,488 | $125,072 | $120,720 | $112,761 | |||||||||||||||||||||||||||
FIXED ANNUITIES ACCOUNT VALUE (5) | ||||||||||||||||||||||||||||||||
Account value, beginning of period | $19,600 | $19,655 | $19,270 | $19,386 | $19,520 | |||||||||||||||||||||||||||
Premiums and deposits (2) | 482 | 210 | 828 | 757 | 562 | |||||||||||||||||||||||||||
Withdrawals, surrenders and contract benefits | (425) | (447) | (594) | (1,033) | (775) | |||||||||||||||||||||||||||
Net flows (3) | 57 | (237) | 234 | (276) | (213) | |||||||||||||||||||||||||||
Interest credited | 152 | 168 | 160 | 156 | 148 | |||||||||||||||||||||||||||
Other | 31 | 14 | (9) | 4 | (69) | |||||||||||||||||||||||||||
Account value, end of period | $19,840 | $19,600 | $19,655 | $19,270 | $19,386 | |||||||||||||||||||||||||||
INSTITUTIONAL GROUP ANNUITIES ACCOUNT VALUE (1) | ||||||||||||||||||||||||||||||||
Institutional group annuities account value (6) | $363 | $343 | $— | $— | $— | |||||||||||||||||||||||||||
INCOME ANNUITIES (1) | ||||||||||||||||||||||||||||||||
Income annuity insurance liabilities | $4,654 | $4,436 | $4,450 | $4,458 | $4,139 | |||||||||||||||||||||||||||
(1) Includes general account and separate account. | ||||||||||||||||||||||||||||||||
(2) Includes premiums and deposits directed to the general account investment option of variable products. | ||||||||||||||||||||||||||||||||
(3) Deposits and withdrawals include policy exchanges. | ||||||||||||||||||||||||||||||||
(4) Includes the interest credited on the general account option of variable products. | ||||||||||||||||||||||||||||||||
(5) Includes fixed index annuities. | ||||||||||||||||||||||||||||||||
(6) Reflects institutional group annuities issued beginning in April 2024. |
Financial Supplement | 9 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
VARIABLE AND SHIELD LEVEL ANNUITY SALES | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Shield Level Annuities (1) | $1,894 | $2,023 | $1,861 | $1,823 | $1,865 | $5,778 | $5,034 | |||||||||||||||||||||||||||||||||||||
GMWB | 79 | 91 | 87 | 87 | 89 | 257 | 315 | |||||||||||||||||||||||||||||||||||||
GMDB only | 54 | 62 | 64 | 43 | 58 | 180 | 177 | |||||||||||||||||||||||||||||||||||||
GMIB | 4 | 7 | 5 | 6 | 6 | 16 | 18 | |||||||||||||||||||||||||||||||||||||
Total variable and Shield Level annuity sales | $2,031 | $2,183 | $2,017 | $1,959 | $2,018 | $6,231 | $5,544 | |||||||||||||||||||||||||||||||||||||
FIXED AND INCOME ANNUITY SALES | ||||||||||||||||||||||||||||||||||||||||||||
Fixed index annuities (2) | $141 | $160 | $191 | $45 | $58 | $492 | $278 | |||||||||||||||||||||||||||||||||||||
Fixed deferred annuities | 339 | 48 | 637 | 708 | 502 | 1,024 | 1,976 | |||||||||||||||||||||||||||||||||||||
Single premium immediate annuities | 10 | 10 | 12 | 16 | 15 | 32 | 52 | |||||||||||||||||||||||||||||||||||||
Other fixed and income annuities | 7 | 7 | 16 | 12 | 7 | 30 | 22 | |||||||||||||||||||||||||||||||||||||
Total fixed and income annuity sales | $497 | $225 | $856 | $781 | $582 | $1,578 | $2,328 | |||||||||||||||||||||||||||||||||||||
(1) Shield Level Annuities refers to our suite of structured annuities consisting of products marketed under various names. | ||||||||||||||||||||||||||||||||||||||||||||
(2) Represents 100% of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. |
Financial Supplement | 10 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Adjusted revenues | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Premiums | $117 | $118 | $119 | $129 | $124 | $354 | $381 | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 70 | 55 | (13) | 73 | 57 | 112 | 192 | |||||||||||||||||||||||||||||||||||||
Net investment income | 112 | 121 | 107 | 103 | 115 | 340 | 334 | |||||||||||||||||||||||||||||||||||||
Other revenues | 4 | 3 | 4 | 9 | 3 | 11 | 8 | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $303 | $297 | $217 | $314 | $299 | $817 | $915 | |||||||||||||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | $247 | $155 | $150 | $197 | $302 | $552 | $697 | |||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | 26 | 25 | 25 | 28 | 25 | 76 | 69 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | 23 | 24 | 24 | 24 | 26 | 71 | 80 | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Other operating costs | 39 | 41 | 64 | 59 | 39 | 144 | 144 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | 335 | 245 | 263 | 308 | 392 | 843 | 990 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) before provision for income tax | (32) | 52 | (46) | 6 | (93) | (26) | (75) | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | (7) | 10 | (10) | 2 | (20) | (7) | (18) | |||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) | $(25) | $42 | $(36) | $4 | $(73) | $(19) | $(57) |
Financial Supplement | 11 |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
LIFE ACCOUNT VALUE: GENERAL ACCOUNT | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | |||||||||||||||||||||||||||
Universal and variable universal life account value, beginning of period | $2,566 | $2,561 | $2,550 | $2,545 | $2,559 | |||||||||||||||||||||||||||
Premiums and deposits (1) | 60 | 60 | 61 | 60 | 57 | |||||||||||||||||||||||||||
Withdrawals, surrenders and contract benefits | (30) | (39) | (36) | (39) | (60) | |||||||||||||||||||||||||||
Net flows | 30 | 21 | 25 | 21 | (3) | |||||||||||||||||||||||||||
Net transfers from (to) separate account | 9 | 12 | 16 | 7 | 20 | |||||||||||||||||||||||||||
Interest credited | 23 | 21 | 22 | 29 | 25 | |||||||||||||||||||||||||||
Policy charges and other | (49) | (49) | (52) | (52) | (56) | |||||||||||||||||||||||||||
Universal and variable universal life account value, end of period | $2,579 | $2,566 | $2,561 | $2,550 | $2,545 | |||||||||||||||||||||||||||
LIFE ACCOUNT VALUE: SEPARATE ACCOUNT | ||||||||||||||||||||||||||||||||
Variable universal life account value, beginning of period | $6,231 | $6,259 | $5,921 | $5,403 | $5,706 | |||||||||||||||||||||||||||
Premiums and deposits | 37 | 38 | 39 | 40 | 40 | |||||||||||||||||||||||||||
Withdrawals, surrenders and contract benefits | (69) | (65) | (78) | (59) | (66) | |||||||||||||||||||||||||||
Net flows | (32) | (27) | (39) | (19) | (26) | |||||||||||||||||||||||||||
Investment performance | 376 | 66 | 444 | 601 | (214) | |||||||||||||||||||||||||||
Net transfers from (to) general account | (8) | (13) | (16) | (7) | (20) | |||||||||||||||||||||||||||
Policy charges and other | (56) | (54) | (51) | (57) | (43) | |||||||||||||||||||||||||||
Variable universal life account value, end of period | $6,511 | $6,231 | $6,259 | $5,921 | $5,403 | |||||||||||||||||||||||||||
(1) Includes premiums and deposits directed to the general account investment option of variable products. |
Financial Supplement | 12 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
LIFE SALES | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Total life sales | $30 | $28 | $29 | $29 | $25 | $87 | $73 |
As of | ||||||||||||||||||||||||||||||||
LIFE INSURANCE IN-FORCE | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | |||||||||||||||||||||||||||
Whole Life | ||||||||||||||||||||||||||||||||
Life Insurance in-force, before reinsurance | $16,995 | $17,192 | $17,368 | $17,561 | $17,704 | |||||||||||||||||||||||||||
Life Insurance in-force, net of reinsurance | $2,903 | $2,915 | $2,936 | $2,962 | $2,979 | |||||||||||||||||||||||||||
Term Life | ||||||||||||||||||||||||||||||||
Life Insurance in-force, before reinsurance | $342,341 | $346,510 | $349,700 | $351,824 | $354,489 | |||||||||||||||||||||||||||
Life Insurance in-force, net of reinsurance | $280,706 | $283,452 | $284,862 | $285,366 | $286,440 | |||||||||||||||||||||||||||
Universal and Variable Universal Life | ||||||||||||||||||||||||||||||||
Life Insurance in-force, before reinsurance | $43,179 | $43,322 | $43,818 | $44,087 | $44,202 | |||||||||||||||||||||||||||
Life Insurance in-force, net of reinsurance | $33,084 | $33,029 | $33,391 | $33,482 | $33,373 | |||||||||||||||||||||||||||
Financial Supplement | 13 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Adjusted revenues | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Premiums | $1 | $— | $— | $4 | $2 | $1 | $3 | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 94 | 106 | 33 | 118 | 105 | 233 | 348 | |||||||||||||||||||||||||||||||||||||
Net investment income | 275 | 315 | 316 | 271 | 300 | 906 | 870 | |||||||||||||||||||||||||||||||||||||
Other revenues | 7 | 8 | 7 | 9 | 6 | 22 | 20 | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $377 | $429 | $356 | $402 | $413 | $1,162 | $1,241 | |||||||||||||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | $(313) | $378 | $673 | $352 | $183 | $738 | $950 | |||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | 60 | 53 | 69 | 71 | 67 | 182 | 203 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Other operating costs | 46 | 35 | 46 | 44 | 43 | 127 | 123 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | (207) | 466 | 788 | 467 | 293 | 1,047 | 1,276 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) before provision for income tax | 584 | (37) | (432) | (65) | 120 | 115 | (35) | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 121 | (7) | (91) | (15) | 25 | 23 | (8) | |||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) | $463 | $(30) | $(341) | $(50) | $95 | $92 | $(27) |
Financial Supplement | 14 |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
UNIVERSAL LIFE WITH SECONDARY GUARANTEES ACCOUNT VALUE | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | |||||||||||||||||||||||||||
Account value, beginning of period | $4,914 | $4,984 | $5,052 | $5,125 | $5,188 | |||||||||||||||||||||||||||
Premiums and deposits (1) | 158 | 166 | 162 | 160 | 162 | |||||||||||||||||||||||||||
Withdrawals, surrenders and contract benefits | (19) | (27) | (22) | (24) | (18) | |||||||||||||||||||||||||||
Net flows | 139 | 139 | 140 | 136 | 144 | |||||||||||||||||||||||||||
Interest credited | 41 | 41 | 42 | 43 | 44 | |||||||||||||||||||||||||||
Policy charges and other | (246) | (250) | (250) | (252) | (251) | |||||||||||||||||||||||||||
Account value, end of period | $4,848 | $4,914 | $4,984 | $5,052 | $5,125 |
As of | ||||||||||||||||||||||||||||||||
LIFE INSURANCE IN-FORCE | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | |||||||||||||||||||||||||||
Universal Life with Secondary Guarantees | ||||||||||||||||||||||||||||||||
Life Insurance in-force, before reinsurance | $69,078 | $69,387 | $69,834 | $70,365 | $70,803 | |||||||||||||||||||||||||||
Life Insurance in-force, net of reinsurance | $33,879 | $34,026 | $34,311 | $34,606 | $34,673 | |||||||||||||||||||||||||||
(1) Includes premiums and deposits directed to the general account investment option of variable products. |
Financial Supplement | 15 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Adjusted revenues | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Premiums | $— | $— | $— | $— | $— | $— | $— | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Net investment income | 178 | 178 | 168 | 163 | 160 | 524 | 460 | |||||||||||||||||||||||||||||||||||||
Other revenues | 5 | — | 5 | 6 | 2 | 10 | (4) | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $183 | $178 | $173 | $169 | $162 | $534 | $456 | |||||||||||||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | $— | $— | $— | $— | $— | $— | $— | |||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | 118 | 109 | 109 | 104 | 103 | 336 | 284 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | 38 | 38 | 38 | 39 | 38 | 114 | 114 | |||||||||||||||||||||||||||||||||||||
Other operating costs | 14 | 13 | 15 | 24 | 12 | 42 | 39 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | 170 | 160 | 162 | 167 | 153 | 492 | 437 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | 13 | 18 | 11 | 2 | 9 | 42 | 19 | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | (17) | (9) | 17 | (2) | (4) | (9) | (14) | |||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) after provision for income tax | 30 | 27 | (6) | 4 | 13 | 51 | 33 | |||||||||||||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 2 | — | 2 | 1 | 2 | 4 | 4 | |||||||||||||||||||||||||||||||||||||
Less: Preferred stock dividends | 26 | 25 | 26 | 25 | 26 | 77 | 77 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) | $2 | $2 | $(34) | $(22) | $(15) | $(30) | $(48) | |||||||||||||||||||||||||||||||||||||
INSTITUTIONAL SPREAD MARGIN BUSINESS ACCOUNT BALANCE | ||||||||||||||||||||||||||||||||||||||||||||
Institutional spread margin business account balance | $11,033 | $10,974 | $10,718 | $10,588 | $10,525 |
Financial Supplement | 17 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
CHANGE IN MARKET RISK BENEFITS | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Market risk benefits mark-to-market | $(791) | $228 | $1,343 | $(852) | $886 | $780 | $1,755 | |||||||||||||||||||||||||||||||||||||
Market risk benefits fees, net of claims | 172 | 135 | 116 | 182 | 193 | 423 | 453 | |||||||||||||||||||||||||||||||||||||
Ceded reinsurance | 9 | (7) | (19) | 7 | (15) | (17) | (38) | |||||||||||||||||||||||||||||||||||||
Total change in market risk benefits | $(610) | $356 | $1,440 | $(663) | $1,064 | $1,186 | $2,170 | |||||||||||||||||||||||||||||||||||||
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
NET DERIVATIVE GAINS (LOSSES) | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Net derivative gains (losses): | ||||||||||||||||||||||||||||||||||||||||||||
Variable annuity hedges | $835 | $137 | $67 | $1,263 | $(1,186) | $1,039 | $(894) | |||||||||||||||||||||||||||||||||||||
Shield embedded derivatives | (976) | (697) | (1,817) | (2,136) | 773 | (3,490) | (1,993) | |||||||||||||||||||||||||||||||||||||
ULSG hedges | 113 | (97) | (212) | 246 | (500) | (196) | (443) | |||||||||||||||||||||||||||||||||||||
Other hedges and embedded derivatives | (71) | (14) | 28 | (73) | 48 | (57) | 18 | |||||||||||||||||||||||||||||||||||||
Subtotal | (99) | (671) | (1,934) | (700) | (865) | (2,704) | (3,312) | |||||||||||||||||||||||||||||||||||||
Investment hedge adjustments | 6 | 9 | 13 | 19 | 25 | 28 | 86 | |||||||||||||||||||||||||||||||||||||
Total net derivative gains (losses) | $(93) | $(662) | $(1,921) | $(681) | $(840) | $(2,676) | $(3,226) |
Financial Supplement | 18 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
NOTABLE ITEMS IMPACTING ADJUSTED EARNINGS | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Actuarial items and other insurance adjustments | $(524) | $— | $366 | $— | $(51) | $(158) | $(51) | |||||||||||||||||||||||||||||||||||||
Legal matters | — | — | — | 12 | — | — | — | |||||||||||||||||||||||||||||||||||||
Total notable items (1) | $(524) | $— | $366 | $12 | $(51) | $(158) | $(51) | |||||||||||||||||||||||||||||||||||||
NOTABLE ITEMS BY SEGMENT AND CORPORATE & OTHER | ||||||||||||||||||||||||||||||||||||||||||||
Annuities | $(20) | $— | $— | $— | $(28) | $(20) | $(28) | |||||||||||||||||||||||||||||||||||||
Life | 66 | — | 73 | — | 71 | 139 | 71 | |||||||||||||||||||||||||||||||||||||
Run-off | (570) | — | 293 | — | (94) | (277) | (94) | |||||||||||||||||||||||||||||||||||||
Corporate & Other | — | — | — | 12 | — | — | — | |||||||||||||||||||||||||||||||||||||
Total notable items (1) | $(524) | $— | $366 | $12 | $(51) | $(158) | $(51) | |||||||||||||||||||||||||||||||||||||
(1) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. |
Financial Supplement | 19 |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
VARIABLE ANNUITY SEPARATE ACCOUNT RETURNS | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | |||||||||||||||||||||||||||
Total Quarterly VA separate account gross returns | 6.14% | 0.91% | 5.96% | 10.25% | (3.65)% | |||||||||||||||||||||||||||
TOTAL VARIABLE ANNUITY SEPARATE ACCOUNT ALLOCATIONS | ||||||||||||||||||||||||||||||||
Percent allocated to equity funds | 31.69% | 31.60% | 31.54% | 30.59% | 29.91% | |||||||||||||||||||||||||||
Percent allocated to bond funds/other funds | 9.02% | 9.02% | 8.83% | 8.99% | 9.28% | |||||||||||||||||||||||||||
Percent allocated to target volatility funds | 18.60% | 18.59% | 18.67% | 19.06% | 19.23% | |||||||||||||||||||||||||||
Percent allocated to balanced funds | 40.69% | 40.79% | 40.96% | 41.36% | 41.58% | |||||||||||||||||||||||||||
Financial Supplement | 20 |
September 30, 2024 | December 31, 2023 | |||||||||||||||||||||||||
Amount | % of Total | Amount | % of Total | |||||||||||||||||||||||
Fixed maturity securities: | ||||||||||||||||||||||||||
U.S. corporate securities | $38,060 | 30.57% | $35,755 | 29.97% | ||||||||||||||||||||||
Foreign corporate securities | 12,399 | 9.96% | 11,665 | 9.78% | ||||||||||||||||||||||
U.S. government and agency securities | 7,569 | 6.08% | 8,419 | 7.06% | ||||||||||||||||||||||
Residential mortgage-backed securities | 7,943 | 6.38% | 7,430 | 6.23% | ||||||||||||||||||||||
Commercial mortgage-backed securities | 6,493 | 5.22% | 6,410 | 5.37% | ||||||||||||||||||||||
Asset-backed securities | 6,272 | 5.04% | 6,406 | 5.37% | ||||||||||||||||||||||
State and political subdivision securities | 3,541 | 2.84% | 3,874 | 3.25% | ||||||||||||||||||||||
Foreign government securities | 1,021 | 0.82% | 1,032 | 0.85% | ||||||||||||||||||||||
Total fixed maturity securities | 83,298 | 66.91% | 80,991 | 67.88% | ||||||||||||||||||||||
Equity securities | 87 | 0.07% | 102 | 0.09% | ||||||||||||||||||||||
Mortgage loans: | ||||||||||||||||||||||||||
Commercial mortgage loans | 13,255 | 10.65% | 13,193 | 11.06% | ||||||||||||||||||||||
Residential mortgage loans | 5,329 | 4.28% | 5,007 | 4.20% | ||||||||||||||||||||||
Agricultural mortgage loans | 4,521 | 3.63% | 4,445 | 3.73% | ||||||||||||||||||||||
Allowance for credit losses | (167) | (0.13)% | (137) | (0.12)% | ||||||||||||||||||||||
Total mortgage loans, net | 22,938 | 18.43% | 22,508 | 18.87% | ||||||||||||||||||||||
Policy loans | 1,387 | 1.11% | 1,331 | 1.12% | ||||||||||||||||||||||
Limited partnerships and limited liability companies | 4,870 | 3.91% | 4,946 | 4.14% | ||||||||||||||||||||||
Cash, cash equivalents and short-term investments | 7,442 | 5.98% | 5,020 | 4.21% | ||||||||||||||||||||||
Other invested assets: | ||||||||||||||||||||||||||
Derivatives: | ||||||||||||||||||||||||||
Interest rate | 272 | 0.22% | 245 | 0.20% | ||||||||||||||||||||||
Equity market | 2,746 | 2.21% | 2,993 | 2.51% | ||||||||||||||||||||||
Foreign currency exchange rate | 412 | 0.33% | 449 | 0.38% | ||||||||||||||||||||||
Credit | 20 | 0.02% | 27 | 0.02% | ||||||||||||||||||||||
Total derivatives | 3,450 | 2.78% | 3,714 | 3.11% | ||||||||||||||||||||||
ICOLI | 661 | 0.53% | 340 | 0.28% | ||||||||||||||||||||||
FHLB common stock | 242 | 0.19% | 245 | 0.21% | ||||||||||||||||||||||
Other | 109 | 0.09% | 110 | 0.09% | ||||||||||||||||||||||
Total other invested assets | 4,462 | 3.59% | 4,409 | 3.69% | ||||||||||||||||||||||
Total investments and cash and cash equivalents | $124,484 | 100.00% | $119,307 | 100.00% |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | ||||||||||||||||||||||||||||
Adjusted net investment income yield (1) | 4.26% | 4.39% | 4.25% | 4.16% | 4.20% | |||||||||||||||||||||||||||
(1) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. |
Financial Supplement | 21 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
COMBINED REVENUES AND EXPENSES (1) | PRELIMINARY September 30, 2024 (2) | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | PRELIMINARY September 30, 2024 (2) | September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Total revenues (Line 9) | $2,800 | $3,656 | $2,229 | $6,103 | $4,571 | $8,685 | $9,293 | |||||||||||||||||||||||||||||||||||||
Total benefits and expenses before dividends to policyholders (Line 28) | $3,200 | $4,027 | $2,675 | $8,337 | $3,474 | $9,902 | $9,000 | |||||||||||||||||||||||||||||||||||||
COMBINED NET INCOME (LOSS) (1) | ||||||||||||||||||||||||||||||||||||||||||||
Gain (loss) from operations net of taxes and dividends to policyholders (Line 33) | $(500) | $(373) | $(441) | $(2,217) | $1,096 | $(1,314) | $296 | |||||||||||||||||||||||||||||||||||||
Net realized capital gains (losses), net of taxes and certain transfers to interest maintenance reserve (Line 34) | 200 | (588) | 423 | 427 | (233) | 35 | (1,057) | |||||||||||||||||||||||||||||||||||||
Net income (loss) (Line 35) | $(300) | $(961) | $(18) | $(1,790) | $863 | $(1,279) | $(761) | |||||||||||||||||||||||||||||||||||||
For the Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
NORMALIZED STATUTORY EARNINGS (LOSS) (3), (4) | PRELIMINARY September 30, 2024 (2) | September 30, 2023 | ||||||||||||||||||||||||||||||||||||||||||
(In billions) | ||||||||||||||||||||||||||||||||||||||||||||
Statutory net gain (loss) from operations, pre-tax (5) | $(1.3) | $0.5 | ||||||||||||||||||||||||||||||||||||||||||
Add: net realized capital gains (losses) | 0.1 | (1.4) | ||||||||||||||||||||||||||||||||||||||||||
Add: change in total asset requirement at CTE98, net of the change in VA reserves (5) | (1.6) | 0.3 | ||||||||||||||||||||||||||||||||||||||||||
Add: unrealized gains (losses) on VA & Shield hedging program and other equity risk management strategies | 0.6 | 0.2 | ||||||||||||||||||||||||||||||||||||||||||
Add: impact of actuarial items and other insurance adjustments (5) | 1.1 | 0.2 | ||||||||||||||||||||||||||||||||||||||||||
Normalized statutory earnings (loss) | $(1.1) | $(0.2) | ||||||||||||||||||||||||||||||||||||||||||
(1) Combined statutory results are for Brighthouse Life Insurance Company, Brighthouse Life Insurance Company of NY and New England Life Insurance Company. | ||||||||||||||||||||||||||||||||||||||||||||
(2) Reflects preliminary statutory results for the three months and nine months ended September 30, 2024. | ||||||||||||||||||||||||||||||||||||||||||||
(3) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||||||||||||||
(4) Normalized statutory earnings (loss), presented in billions, is for Brighthouse Life Insurance Company and New England Life Insurance Company. | ||||||||||||||||||||||||||||||||||||||||||||
(5) As a result of actions to hedge Shield new business on a stand-alone basis and related actions to develop a separate hedging strategy for the legacy VA and Shield blocks, CTE70 decreased ~$630 million and total asset requirement at CTE98 increased ~$1.0 billion for the nine months ended September 30, 2024. The ~$1.0 billion impact to CTE98 is reflected in ‘impact of actuarial items and other insurance adjustments’ to normalize the effect of these actions. |
Financial Supplement | 22 |
As of | ||||||||||||||||||||||||||||||||||||||
COMBINED ASSETS, LIABILITIES, AND CAPITAL AND SURPLUS (1) | PRELIMINARY September 30, 2024 (2) | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | |||||||||||||||||||||||||||||||||
Total assets (Line 28) | $202,600 | $198,413 | $199,778 | $197,335 | $188,472 | |||||||||||||||||||||||||||||||||
Total liabilities (Line 28) | $198,400 | $194,539 | $195,275 | $192,572 | $182,758 | |||||||||||||||||||||||||||||||||
Total capital and surplus (Line 38) | $4,200 | $3,874 | $4,503 | $4,763 | $5,714 | |||||||||||||||||||||||||||||||||
COMBINED TAC AND RBC RATIO (1), (3) | ||||||||||||||||||||||||||||||||||||||
Combined total adjusted capital | $5,700 | $5,397 | $6,030 | $6,283 | $7,251 | |||||||||||||||||||||||||||||||||
Combined risk-based capital ratio (4) | 400%-420% | 380%-400% | 415%-435% | 428% | 400%-420% | |||||||||||||||||||||||||||||||||
DIVIDENDS PAID TO HOLDING COMPANY (1), (3) | ||||||||||||||||||||||||||||||||||||||
Total dividends paid | $— | $— | $— | $350 | $— | |||||||||||||||||||||||||||||||||
(1) Combined statutory results are for Brighthouse Life Insurance Company and New England Life Insurance Company. | ||||||||||||||||||||||||||||||||||||||
(2) Reflects preliminary statutory results as of September 30, 2024. | ||||||||||||||||||||||||||||||||||||||
(3) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||||||||
(4) The RBC ratio is reported as a preliminary range for all periods, except those ended December 31. |
Financial Supplement | A-1 |
Financial Supplement | A-2 |
Non-GAAP financial measures: | Most directly comparable GAAP financial measures: | |||||||||||||
(i) | adjusted earnings | (i) | net income (loss) available to shareholders (1) | |||||||||||
(ii) | adjusted earnings, less notable items | (ii) | net income (loss) available to shareholders (1) | |||||||||||
(iii) | adjusted revenues | (iii) | revenues | |||||||||||
(iv) | adjusted expenses | (iv) | expenses | |||||||||||
(v) | adjusted earnings per common share | (v) | earnings per common share, diluted (1) | |||||||||||
(vi) | adjusted earnings per common share, less notable items | (vi) | earnings per common share, diluted (1) | |||||||||||
(vii) | adjusted return on common equity | (vii) | return on common equity (2) | |||||||||||
(viii) | adjusted return on common equity, less notable items | (viii) | return on common equity (2) | |||||||||||
(ix) | adjusted net investment income | (ix) | net investment income | |||||||||||
(x) | adjusted net investment income yield | (x) | net investment income yield | |||||||||||
__________________ | ||||||||||||||
(1) Brighthouse uses net income (loss) available to shareholders to refer to net income (loss) available to Brighthouse Financial, Inc.’s common shareholders, and earnings per common share, diluted to refer to net income (loss) available to shareholders per common share. | ||||||||||||||
(2) Brighthouse uses return on common equity to refer to return on Brighthouse Financial, Inc.’s common stockholders' equity. |
Financial Supplement | A-3 |
Financial Supplement | A-4 |
Financial Supplement | A-5 |
Financial Supplement | A-6 |
AOCI | Accumulated other comprehensive income (loss) | ||||
CTE | Conditional tail expectations | ||||
DAC | Deferred policy acquisition costs | ||||
FHLB | Federal Home Loan Bank | ||||
GAAP | Accounting principles generally accepted in the United States of America | ||||
GMDB | Guaranteed minimum death benefits | ||||
GMIB | Guaranteed minimum income benefits | ||||
GMWB | Guaranteed minimum withdrawal benefits | ||||
ICOLI | Insurance company-owned life insurance | ||||
NDGL | Net derivative gains (losses) | ||||
NIGL | Net investment gains (losses) | ||||
RBC | Risk-based capital | ||||
TAC | Total adjusted capital | ||||
ULSG | Universal life insurance with secondary guarantees | ||||
VA | Variable annuity | ||||
VOBA | Value of business acquired |
Financial Supplement | A-7 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
ADJUSTED EARNINGS, LESS NOTABLE ITEMS (1) | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Net income (loss) available to shareholders | $150 | $9 | $(519) | $(942) | $453 | $(360) | $(272) | |||||||||||||||||||||||||||||||||||||
Less: Net investment gains (losses) | (60) | (120) | (42) | (33) | (53) | (222) | (213) | |||||||||||||||||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | (99) | (671) | (1,934) | (700) | (865) | (2,704) | (3,312) | |||||||||||||||||||||||||||||||||||||
Less: Change in market risk benefits | (610) | 356 | 1,440 | (663) | 1,064 | 1,186 | 2,170 | |||||||||||||||||||||||||||||||||||||
Less: Market value adjustments | (11) | 6 | 4 | (21) | 15 | (1) | 9 | |||||||||||||||||||||||||||||||||||||
Less: Provision for income tax (expense) benefit on reconciling adjustments | 163 | 92 | 111 | 298 | (34) | 366 | 282 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) | 767 | 346 | (98) | 177 | 326 | 1,015 | 792 | |||||||||||||||||||||||||||||||||||||
Less: Notable items | 524 | — | (366) | (12) | 51 | 158 | 51 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings, less notable items | $243 | $346 | $268 | $189 | $275 | $857 | $741 | |||||||||||||||||||||||||||||||||||||
ADJUSTED EARNINGS, LESS NOTABLE ITEMS PER COMMON SHARE (1), (2) | ||||||||||||||||||||||||||||||||||||||||||||
Net income (loss) available to shareholders per common share | $2.47 | $0.12 | $(8.22) | $(14.70) | $6.89 | $(5.82) | $(4.08) | |||||||||||||||||||||||||||||||||||||
Less: Net investment gains (losses) | (0.98) | (1.93) | (0.67) | (0.51) | (0.81) | (3.59) | (3.20) | |||||||||||||||||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | (1.62) | (10.78) | (30.68) | (10.92) | (13.16) | (43.71) | (49.69) | |||||||||||||||||||||||||||||||||||||
Less: Change in market risk benefits | (10.01) | 5.72 | 22.84 | (10.34) | 16.18 | 19.17 | 32.55 | |||||||||||||||||||||||||||||||||||||
Less: Market value adjustments | (0.18) | 0.10 | 0.06 | (0.33) | 0.23 | (0.02) | 0.14 | |||||||||||||||||||||||||||||||||||||
Less: Provision for income tax (expense) benefit on reconciling adjustments | 2.67 | 1.48 | 1.76 | 4.65 | (0.52) | 5.92 | 4.23 | |||||||||||||||||||||||||||||||||||||
Less: Impact of inclusion of dilutive shares | — | — | — | 0.03 | — | 0.09 | 0.07 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings (loss) per common share | 12.58 | 5.57 | (1.56) | 2.73 | 4.97 | 16.32 | 11.82 | |||||||||||||||||||||||||||||||||||||
Less: Notable items | 8.60 | — | (5.81) | (0.19) | 0.78 | 2.54 | 0.76 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings, less notable items per common share | $3.99 | $5.57 | $4.25 | $2.92 | $4.18 | $13.78 | $11.06 | |||||||||||||||||||||||||||||||||||||
(1) See definitions for Non-GAAP and Other Financial Disclosures in this Appendix. | ||||||||||||||||||||||||||||||||||||||||||||
(2) Per share calculations are on a diluted basis and may not recalculate or foot due to rounding. For loss periods, dilutive shares were not included in the calculation as inclusion of such shares would have an anti-dilutive effect. |
Financial Supplement | A-8 |
Four Quarters Cumulative Trailing Basis | ||||||||||||||||||||||||||||||||
ADJUSTED EARNINGS | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | |||||||||||||||||||||||||||
Net income (loss) available to shareholders | $(1,302) | $(999) | $(1,208) | $(1,214) | $(162) | |||||||||||||||||||||||||||
Less: Net investment gains (losses) | (255) | (248) | (192) | (246) | (282) | |||||||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | (3,404) | (4,170) | (5,333) | (4,012) | (5,268) | |||||||||||||||||||||||||||
Less: Change in market risk benefits | 523 | 2,197 | 3,141 | 1,507 | 3,649 | |||||||||||||||||||||||||||
Less: Market value adjustments | (22) | 4 | — | (12) | 6 | |||||||||||||||||||||||||||
Less: Provision for income tax (expense) benefit on reconciling adjustments | 664 | 467 | 500 | 580 | 396 | |||||||||||||||||||||||||||
Adjusted earnings | $1,192 | $751 | $676 | $969 | $1,337 | |||||||||||||||||||||||||||
Five Quarters Average Stockholders' Equity Basis | ||||||||||||||||||||||||||||||||
BRIGHTHOUSE FINANCIAL, INC.’S COMMON STOCKHOLDERS’ EQUITY, EXCLUDING AOCI | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | |||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s stockholders’ equity | $4,575 | $4,451 | $4,774 | $5,041 | $4,973 | |||||||||||||||||||||||||||
Less: Preferred stock, net | 1,699 | 1,699 | 1,699 | 1,699 | 1,699 | |||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s common stockholders’ equity | 2,876 | 2,752 | 3,075 | 3,342 | 3,274 | |||||||||||||||||||||||||||
Less: AOCI | (5,464) | (5,815) | (5,789) | (5,927) | (6,281) | |||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s common stockholders’ equity, excluding AOCI | $8,340 | $8,567 | $8,864 | $9,269 | $9,555 | |||||||||||||||||||||||||||
Five Quarters Average Common Stockholders' Equity Basis | ||||||||||||||||||||||||||||||||
ADJUSTED RETURN ON COMMON EQUITY, EXCLUDING AOCI | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | |||||||||||||||||||||||||||
Return on common equity | (45.3)% | (36.3)% | (39.3)% | (36.3)% | (4.9)% | |||||||||||||||||||||||||||
Return on AOCI | 23.8% | 17.2% | 20.9% | 20.5% | 2.6% | |||||||||||||||||||||||||||
Return on common equity, excluding AOCI | (15.6)% | (11.7)% | (13.6)% | (13.1)% | (1.7)% | |||||||||||||||||||||||||||
Less: Return on net investment gains (losses) | (3.1)% | (2.9)% | (2.2)% | (2.7)% | (3.0)% | |||||||||||||||||||||||||||
Less: Return on net derivative gains (losses), excluding investment hedge adjustments | (40.8)% | (48.7)% | (60.2)% | (43.3)% | (55.1)% | |||||||||||||||||||||||||||
Less: Return on change in market risk benefits | 6.3% | 25.6% | 35.5% | 16.3% | 38.2% | |||||||||||||||||||||||||||
Less: Return on market value adjustments | (0.3)% | —% | —% | (0.1)% | 0.1% | |||||||||||||||||||||||||||
Less: Return on provision for income tax (expense) benefit on reconciling adjustments | 8.0% | 5.5% | 5.7% | 6.2% | 4.1% | |||||||||||||||||||||||||||
Adjusted return on common equity, excluding AOCI | 14.3% | 8.8% | 7.6% | 10.5% | 14.0% | |||||||||||||||||||||||||||
Financial Supplement | A-9 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | September 30, 2024 | September 30, 2023 | ||||||||||||||||||||||||||||||||||||||
Total revenues | $2,018 | $1,427 | $74 | $1,400 | $1,170 | $3,519 | $2,717 | |||||||||||||||||||||||||||||||||||||
Less: Net investment gains (losses) | (60) | (120) | (42) | (33) | (53) | (222) | (213) | |||||||||||||||||||||||||||||||||||||
Less: Net derivative gains (losses) | (93) | (662) | (1,921) | (681) | (840) | (2,676) | (3,226) | |||||||||||||||||||||||||||||||||||||
Less: Investment hedge adjustments | (6) | (9) | (13) | (19) | (25) | (28) | (86) | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $2,177 | $2,218 | $2,050 | $2,133 | $2,088 | $6,445 | $6,242 | |||||||||||||||||||||||||||||||||||||
Total expenses | $1,830 | $1,413 | $688 | $2,574 | $580 | $3,931 | $3,017 | |||||||||||||||||||||||||||||||||||||
Less: Change in market risk benefits | 610 | (356) | (1,440) | 663 | (1,064) | (1,186) | (2,170) | |||||||||||||||||||||||||||||||||||||
Less: Market value adjustments | 11 | (6) | (4) | 21 | (15) | 1 | (9) | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | $1,209 | $1,775 | $2,132 | $1,890 | $1,659 | $5,116 | $5,196 |
Financial Supplement | A-10 |
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
NET INVESTMENT GAINS (LOSSES) | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |||||||||||||||||||||||||||||||||||||
Investment portfolio gains (losses) | $(17) | $(80) | $(32) | $(34) | $(46) | $(129) | $(165) | |||||||||||||||||||||||||||||||||||||
Investment portfolio credit loss (provision) release and (writedowns) | (43) | (40) | (10) | 1 | (7) | (93) | (48) | |||||||||||||||||||||||||||||||||||||
Net investment gains (losses) | $(60) | $(120) | $(42) | $(33) | $(53) | $(222) | $(213) |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
ADJUSTED NET INVESTMENT INCOME YIELD (1) | September 30, 2024 | June 30, 2024 | March 31, 2024 | December 31, 2023 | September 30, 2023 | |||||||||||||||||||||||||||
Investment income yield | 4.40% | 4.52% | 4.39% | 4.29% | 4.34% | |||||||||||||||||||||||||||
Investment fees and expenses | (0.14)% | (0.13)% | (0.14)% | (0.13)% | (0.14)% | |||||||||||||||||||||||||||
Adjusted net investment income yield | 4.26% | 4.39% | 4.25% | 4.16% | 4.20% | |||||||||||||||||||||||||||
(1) See definitions for Non-GAAP and Other Financial Disclosures in this Appendix. |
PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 |
FOR INVESTORS Dana Amante (980) 949-3073 damante@brighthousefinancial.com | FOR MEDIA Deon Roberts (980) 949-3071 deon.roberts@brighthousefinancial.com |